The genetic testing company 23andMe will go public through a partnership with a firm backed by the billionaire Richard Branson, in a deal that has raised fresh privacy questions about the information of millions of customers.

Launched in 2006, 23andMe sells tests to determine consumers’ genetic ancestry and risk of developing certain illnesses, using saliva samples sent in by mail.